STOCK TITAN

3M Reports Third-Quarter 2021 Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

3M reported third-quarter 2021 results with sales rising by 7.1% year-on-year to $8.9 billion. Organic local-currency sales increased by 6.3%, with consumer sales leading at 8.1%. Earnings per share remained flat at $2.45, while operating income fell to $1.8 billion with margins of 20.0%. The company updated its full-year guidance, expecting total sales growth of 9% to 10% and earnings per share between $9.70 and $9.90. Operational cash flow was strong at $1.9 billion, with $1.4 billion returned to shareholders.

Positive
  • Sales increased by 7.1% YoY to $8.9 billion.
  • Organic local-currency sales rose by 6.3%.
  • Strong growth in the Consumer segment at 8.1%.
  • Operating cash flow was $1.9 billion.
  • Returned $1.4 billion to shareholders.
Negative
  • Operating income fell to $1.8 billion, down from previous year.
  • Safety and Industrial segment operating income decreased by 20%.
  • Transportation and Electronics segment operating income fell by 9%.
  • Consumer segment operating income decreased by 3%.

ST. PAUL, Minn., Oct. 26, 2021 /PRNewswire/ -- 3M (NYSE: MMM) today reported third-quarter 2021 results.

"In the face of continued global challenges, the 3M team executed well and delivered broad-based organic growth, along with strong margins and cash flow," said 3M chairman and chief executive officer Mike Roman. "Overall, end-market demand remained strong, and we navigated supply chain disruptions by maintaining a relentless focus on serving and innovating for our customers. Moving ahead, we will continue to invest for the future by investing in strong demand areas aligned with global trends, while improving our operational performance, driving productivity and advancing sustainability."

Third-Quarter Results

Sales grew 7.1 percent year-on-year to $8.9 billion. Organic local-currency sales increased 6.3 percent. Foreign currency translation increased sales by 0.8 percent year-on-year.

Total sales grew 8.1 percent in Consumer, 7.2 percent in Safety and Industrial, 5.8 percent in Transportation and Electronics, and 4.1 percent in Health Care. Organic local-currency sales increased 7.6 percent in Consumer, 6.1 percent in Safety and Industrial, 5.1 percent in Transportation and Electronics, and 3.3 percent in Health Care.

On a geographic basis, total sales grew 7.9 percent in the Americas, 6.8 percent in Asia Pacific, and 5.2 percent in EMEA (Europe, Middle East and Africa). Organic local-currency sales grew 7.4 percent in the Americas, 5.6 percent in Asia Pacific, and 4.2 percent in EMEA.

Third-quarter earnings per share was $2.45 per share, flat year-on-year. Third quarter operating income was $1.8 billion with operating margins of 20.0 percent.

The company's operating cash flow was $1.9 billion with adjusted free cash flow of $1.5 billion contributing to adjusted free cash flow conversion of 107 percent. 3M returned $1.4 billion to shareholders in the third quarter of 2021, including $856 million in cash dividends and $527 million of gross share repurchases. See the "Supplemental Financial Information Non-GAAP Measures" section for applicable information.

Full-Year 2021 Outlook

3M is updating its full-year 2021 sales and earnings expectations to include the company's year-to-date results and reflect the current global supply chain disruptions.


Updated Guidance

Prior Guidance

Total sales growth

9% to 10%

7% to 10%

Organic local-currency sales growth

8% to 9%

6% to 9%

Earnings per share

$9.70 to $9.90

$9.70 to $10.10

3M continues to expect to generate strong cash flow and maintains its full-year free cash flow conversion range of 90 to 100 percent, as referenced in the "Supplemental Financial Information Non-GAAP Measures" section.

Third-Quarter Business Group Discussion

Safety and Industrial

  • Sales of $3.2 billion, up 7.2 percent in U.S. dollars. Organic local-currency sales increased 6.1 percent, and foreign currency translation increased sales by 1.1 percent.
  • On an organic local-currency basis:
    • Sales increased in abrasives, industrial adhesives and tapes, electrical markets, closure and masking systems, and automotive aftermarket, and decreased in roofing granules and personal safety.
    • Sales grew in Asia Pacific and the Americas and declined in EMEA.
  • Segment operating income was $620 million, a decrease of 20 percent year-on-year; operating margins of 19.2 percent.

Transportation and Electronics

  • Sales of $2.5 billion, up 5.8 percent in U.S. dollars. Organic local-currency sales increased 5.1 percent, and foreign currency translation increased sales by 0.7 percent.
  • On an organic local-currency basis:
    • Sales increased in advanced materials, commercial solutions, automotive and aerospace, and transportation safety, and decreased in electronics.
    • Sales grew in the Americas and EMEA and declined in Asia Pacific.
  • Segment operating income was $465 million, a decrease of 9 percent year-on-year; operating margins of 19.0 percent.

Health Care

  • Sales of $2.2 billion, up 4.1 percent in U.S. dollars. Organic local-currency sales increased 3.3 percent and, foreign currency translation increased sales by 0.8 percent.
  • On an organic local-currency basis:
    • Sales increased in food safety, oral care, health information systems, and separation and purification, and decreased in medical solutions.
    • Sales grew in Asia Pacific, EMEA and the Americas.
  • Segment operating income was $529 million, an increase of 7 percent year-on-year; operating margins were 23.5 percent.

Consumer

  • Sales of $1.5 billion, up 8.1 percent in U.S. dollars. Organic local-currency sales increased 7.6 percent, and foreign currency translation increased sales by 0.5 percent.
  • On an organic local-currency basis:
    • Sales increased in stationery and office, consumer health and safety, home improvement, and home care.
    • Sales grew in the Americas and Asia Pacific and declined in EMEA.
  • Segment operating income was $332 million, a decrease 3 percent year-on-year; operating margins were 21.7 percent.

3M will conduct an investor teleconference at 9:00 a.m. EDT (8:00 a.m. CDT) today. Investors can access this conference via the following:

  • Live webcast at http://investors.3M.com.
  • Live telephone:
    Call 800-762-2596 within the U.S. or +1 212-231-2916 outside the U.S. Please join the call at least 10 minutes before the start time.
  • Webcast replay:
    Go to 3M's Investor Relations website at http://investors.3M.com and click on "Quarterly Earnings."
  • Telephone replay:
    Call 800-633-8284 within the U.S. or +1 402-977-9140 outside the U.S. (for both U.S. and outside the U.S., the access code is 21972037). The telephone replay will be available until 11:30 a.m. EDT (10:30 a.m. CDT) on November 2, 2021.

Forward-Looking Statements

This news release contains forward-looking information about 3M's financial results and estimates and business prospects that involve substantial risks and uncertainties. You can identify these statements by the use of words such as "anticipate," "estimate," "expect," "aim," "project," "intend," "plan," "believe," "will," "should," "could," "target," "forecast" and other words and terms of similar meaning in connection with any discussion of future operating or financial performance or business plans or prospects. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, regulatory, capital markets and other external conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) risks related to public health crises such as the global pandemic associated with the coronavirus (COVID-19); (3) foreign currency exchange rates and fluctuations in those rates; (4) liabilities related to certain fluorochemicals, including lawsuits concerning various PFAS-related products and chemistries, and claims and governmental regulatory proceedings and inquiries related to PFAS in a variety of jurisdictions; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10-K for the year ended December 31, 2020, and any subsequent quarterly reports on Form 10-Q (the "Reports"); (6) competitive conditions and customer preferences; (7) the timing and market acceptance of new product offerings; (8) the availability and cost of purchased components, compounds, raw materials, labor, and energy (including oil and natural gas and their derivatives) due to shortages, increased demand and wages, logistics, manufacturing site disruption or supply chain interruptions (including those caused by natural and other disasters and other events); (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (11) operational execution, including scenarios where the Company generates fewer productivity improvements than estimated; (12) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; (13) the Company's credit ratings and its cost of capital; and (14) tax-related external conditions, including changes in tax rates, laws or regulations. Changes in such assumptions or factors could produce significantly different results. A further description of these factors is located in the Reports under "Cautionary Note Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports), as updated by applicable Current Reports on Form 8-K. The information contained in this news release is as of the date indicated. The Company assumes no obligation to update any forward-looking statements contained in this news release as a result of new information or future events or developments.


 

3M Company and Subsidiaries

CONSOLIDATED STATEMENT OF INCOME

(Millions, except per-share amounts)

(Unaudited)




Three months ended
September 30,


Nine months ended
September 30,



2021


2020


2021


2020

Net sales


$

8,942



$

8,350



$

26,743



$

23,601











Operating expenses









Cost of sales


4,853



4,303



14,097



12,217


Selling, general and administrative expenses


1,819



1,677



5,373



5,039


Research, development and related expenses


482



461



1,520



1,422


Gain on sale of businesses








(389)


Total operating expenses


7,154



6,441



20,990



18,289


Operating income


1,788



1,909



5,753



5,312











Other expense (income), net


31



83



113



248











Income before income taxes


1,757



1,826



5,640



5,064


Provision for income taxes


324



391



1,058



1,016


Income of consolidated group


1,433



1,435



4,582



4,048











Income (loss) from unconsolidated subsidiaries, net of taxes


4



(1)



7



(1)


Net income including noncontrolling interest


1,437



1,434



4,589



4,047











Less: Net income (loss) attributable to noncontrolling interest


3



4



7



3











Net income attributable to 3M


$

1,434



$

1,430



$

4,582



$

4,044











Weighted average 3M common shares outstanding – basic


579.6



577.8



580.3



577.2


Earnings per share attributable to 3M common shareholders – basic


$

2.47



$

2.47



$

7.90



$

7.01











Weighted average 3M common shares outstanding – diluted


586.3



582.4



587.1



581.6


Earnings per share attributable to 3M common shareholders – diluted


$

2.45



$

2.45



$

7.81



$

6.95



 

3M Company and Subsidiaries

CONDENSED CONSOLIDATED BALANCE SHEET

(Dollars in millions)

(Unaudited)




September 30,
2021


December 31,
2020

ASSETS





Current assets





Cash and cash equivalents


$

4,878



$

4,634


Marketable securities – current


855



404


Accounts receivable – net


4,916



4,705


Inventories


4,950



4,239


Prepaids


501



675


Other current assets


326



325


Total current assets


16,426



14,982


Property, plant and equipment – net


9,323



9,421


Operating lease right of use assets


840



864


Goodwill and intangible assets – net


19,023



19,637


Other assets


2,666



2,440


Total assets


$

48,278



$

47,344


LIABILITIES AND EQUITY





Current liabilities





Short-term borrowings and current portion of long-term debt


$

1,972



$

806


Accounts payable


2,862



2,561


Accrued payroll


1,019



747


Accrued income taxes


278



300


Operating lease liabilities – current


262



256


Other current liabilities


3,242



3,278


Total current liabilities


9,635



7,948


Long-term debt


16,193



17,989


Other liabilities


7,920




8,476


Total liabilities


33,748



34,413


Total equity


14,530



12,931


Shares outstanding





September 30, 2021: 576,252,803





December 31, 2020: 577,749,638





Total liabilities and equity


$

48,278



$

47,344













 

3M Company and Subsidiaries

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(Dollars in millions)

(Unaudited)




Nine months ended
September 30,



2021


2020

NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES


$

5,449



$

5,598







Cash flows from investing activities:





Purchases of property, plant and equipment


(1,047)



(1,079)


Acquisitions, net of cash acquired




(25)


Purchases and proceeds from sale or maturities of marketable securities and investments – net


(447)



170


Proceeds from sale of businesses, net of cash sold




576


Other investing activities


62



37







NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES


(1,432)



(321)







Cash flows from financing activities:





Change in debt


(445)



(870)


Purchases of treasury stock


(1,261)



(366)


Proceeds from issuances of treasury stock pursuant to stock option and benefit plans


566



325


Dividends paid to shareholders


(2,572)



(2,540)


Other financing activities


(21)



(47)







NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES


(3,733)



(3,498)







Effect of exchange rate changes on cash and cash equivalents


(40)



(11)







Net increase (decrease) in cash and cash equivalents


244



1,768


Cash and cash equivalents at beginning of year


4,634



2,353







Cash and cash equivalents at end of period


$

4,878



$

4,121


 


3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES

(Unaudited)


(Dollars in millions, except
per share amounts)


Operating

Income


Operating

Income

Margin


Income

Before

Taxes


Provision

for

Income

Taxes


Effective

Tax

Rate


Net Income

Attributable

to 3M


Earnings

Per

Diluted

Share


Earnings

per

diluted

share

percent

change

Q3 2020 GAAP


$

1,909



22.9

%


$

1,826



$

391



21.5

%


$

1,430



$

2.45




Adjustments for special items:

















None







0










Q3 2020 adjusted amounts (non-GAAP measures) (a)


$

1,909



22.9

%


$

1,826



$

391



21.5

%


$

1,430



$

2.45





















Q3 2021 GAAP


$

1,788



20.0

%


$

1,757



$

324



18.4

%


$

1,434



$

2.45



%

Adjustments for special items:

















None

















Q3 2021 adjusted amounts (non-GAAP measures) (a)


$

1,788



20.0

%


$

1,757



$

324



18.4

%


$

1,434



$

2.45



%


(Dollars in millions, except
per share amounts)


Operating

Income


Operating

Income

Margin


Income

Before

Taxes


Provision

for

Income

Taxes


Effective

Tax

Rate


Net Income

Attributable

to 3M


Earnings

Per

Diluted

Share


Earnings

per

diluted

share

percent

change

Nine months ended September 30, 2020 GAAP


$

5,312



22.5

%


$

5,064



$

1,016



20.1

%


$

4,044



$

6.95




Adjustments for special items:

















Significant litigation-related charges/benefits


17





17



56





(39)



(0.07)




Gain/loss on sale of businesses


(389)





(389)



(86)





(303)



(0.52)




Divestiture-related restructuring actions


55





55



9





46



0.08




Nine months ended September 30, 2020 adjusted amounts
(non-GAAP measures) (a)


$

4,995



21.2

%


$

4,747



$

995



21.0

%


$

3,748



$

6.44





















Nine months ended September 30, 2021 GAAP


$

5,753



21.5

%


$

5,640



$

1,058



18.8

%


$

4,582



$

7.81



12

%

Adjustments for special items:

















None

















Nine months ended September 30, 2021 adjusted amounts
(non-GAAP measures) (a)


$

5,753



21.5

%


$

5,640



$

1,058



18.8

%


$

4,582



$

7.81



21

%


__________________________

(a)

In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides non-GAAP measures that adjust for the impact of special items. Special items for the periods presented include the items described in the section entitled "Description of Special Items". Operating income (measure of segment operating performance), income before taxes, net income, earnings per share, and effective tax rate are all measures for which 3M provides the reported GAAP measure and a measure adjusted for special items. The adjusted measures are not in accordance with, nor are they a substitute for, GAAP measures. The Company considers these non-GAAP measures in evaluating and managing the Company's operations. The Company believes that discussion of results adjusted for these items is meaningful to investors as it provides a useful analysis of ongoing underlying operating trends. The determination of these items may not be comparable to similarly titled measures used by other companies.

 

3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)

(Unaudited)




Three months ended
September 30,


Nine months ended
September 30,

Major GAAP Cash Flow Categories (dollars in millions)


2021


2020


2021


2020

Net cash provided by (used in) operating activities


$

1,874



$

2,480



$

5,449



$

5,598


Net cash provided by (used in) investing activities


(389)



(523)



(1,432)



(321)


Net cash provided by (used in) financing activities


(1,299)



(2,097)



(3,733)



(3,498)




Free cash flow (non-GAAP measure) (dollars in billions)


Full-Year 2021

Forecast

Net cash provided by (used in) operating activities

$6.7 to $7.3

Purchases of property, plant and equipment

($1.5 to $1.6)

Free cash flow (b)

$5.1 to $5.8



Net income attributable to 3M

$5.7 to $5.8

Free cash flow conversion (b)

90% to 100%





Three months ended
September 30,


Nine months ended
September 30,

Adjusted Free Cash Flow (non-GAAP measure) (dollars in millions)


2021


2020


2021


2020

Net cash provided by (used in) operating activities


$

1,874



$

2,480



$

5,449



$

5,598


Purchases of property, plant and equipment


(343)



(368)



(1,047)



(1,079)


Free cash flow


1,531



2,112



4,402



4,519


Adjustments for special items:









Significant litigation-related after-tax payment impacts


5



10



10



74


TCJA transition tax payment




33



77



33


Divestiture-related restructuring after-tax payment impacts


1



6



5



6


Adjusted free cash flow (c)


$

1,537



$

2,161



$

4,494



$

4,632











Net income attributable to 3M


$

1,434



$

1,430



$

4,582



$

4,044


Adjustments for special items:









Significant litigation-related charges/benefits








(39)


(Gain)/loss on sale of businesses








(303)


Divestiture-related restructuring actions








46


Adjusted net income attributable to 3M (a)


$

1,434



$

1,430



$

4,582



$

3,748


Adjusted free cash flow conversion (c)


107

%


151

%


98

%


124

%


______________________________________

(b)

Free cash flow and free cash flow conversion are not defined under U.S. generally accepted accounting principles (GAAP). Therefore, they should not be considered a substitute for income or cash flow data prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by other companies. The Company defines free cash flow as net cash provided by operating activities less purchases of property, plant and equipment. It should not be inferred that the entire free cash flow amount is available for discretionary expenditures. The Company defines free cash flow conversion as free cash flow divided by net income attributable to 3M. The Company believes free cash flow and free cash flow conversion are meaningful to investors as they function as useful measures of performance and the Company uses these measures as an indication of the strength of the company and its ability to generate cash.



(c) 

Adjusted free cash flow and adjusted free cash flow conversion are not defined under U.S. GAAP. Therefore, they should not be considered a substitute for income or cash flow data prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by other companies. The Company defines adjusted free cash flow as net cash provided by operating activities, adjusted for special items, less purchases of property, plant and equipment. Cash payments associated with special items in the determination of adjusted free cash flow are reflected net of applicable tax using the U.S. statutory corporate tax rate during the period of payment. It should not be inferred that the entire adjusted free cash flow amount is available for discretionary expenditures. The Company defines adjusted free cash flow conversion as adjusted free cash flow divided by net income attributable to 3M, adjusted for special items. Special items for the periods presented include the items described in section entitled "Description of Special Items". The Company believes adjusted free cash flow and adjusted free cash flow conversion are meaningful to investors as they are useful measures of performance and the Company uses these measures as an indication of the strength of the company and its ability to generate cash.

 

3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)




Adjusted EBITDA
(non-GAAP measure) (d)


 

Adjusted EBITDA Margin
(non-GAAP measure) (d)



Three months ended September 30,


Three months ended September 30,

(Dollars in millions)


2021


2020


2021


2020

Safety and Industrial


$

769



$

923



23.8

%


30.6

%

Transportation and Electronics


571



613



23.3

%


26.5

%

Health Care


687



653



30.5

%


30.2

%

Consumer


369



378



24.2

%


26.8

%

Corporate and Unallocated


(1)



(35)








Elimination of Dual Credit


(131)



(142)








Total Company


$

2,264



$

2,390



25.3

%


28.6

%












Adjusted EBITDA
(non-GAAP measure) (d)


 

Adjusted EBITDA Margin
(non-GAAP measure) (d)



Nine months ended September 30,


Nine months ended September 30,

(Dollars in millions)


2021


2020


2021


2020

Safety and Industrial


$

2,589



$

2,508



26.4

%


29.2

%

Transportation and Electronics


1,910



1,654



25.6

%


25.5%

%

Health Care


2,091



1,714



30.9

%


28.2

%

Consumer


1,040



990



23.7%

%


25.4

%

Corporate and Unallocated


(41)



(84)








Elimination of Dual Credit


(428)



(374)








Total Company


$

7,161



$

6,408



26.8

%


27.2

%










Three months ended


Nine months ended

Adjusted EBITDA (non-GAAP measure) (dollars in millions)


September 30, 2021


September 30, 2020


September 30, 2021


September 30, 2020

Net sales


$

8,942



$

8,350



$

26,743



$

23,601











Net income attributable to 3M


1,434



1,430



4,582



4,044


Add/(subtract):









Net income/(loss) attributable to noncontrolling interest


3



4



7



3


(Income)/loss from unconsolidated subsidiaries, net of taxes


(4)



1



(7)



1


Provision for income taxes


324



391



1,058



1,016


Other expense/(income):









Interest (Income)/expense


111



123



352



364


Pension & OPEB non-service cost (benefit)


(80)



(40)



(239)



(116)


Depreciation and amortization expense


476



481



1,408



1,413


Adjustments for special items:









Significant litigation-related charges/(benefits)








17


(Gain)/loss on sale of businesses








(389)


Divestiture-related restructuring actions








55


Adjusted EBITDA (d)


$

2,264



$

2,390



$

7,161



$

6,408











Adjusted EBITDA margin (d)


25.3

%


28.6

%


26.8

%


27.2

%


3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)




Adjusted EBITDA (non-GAAP measure)
Three months ended September 30, 2021

(dollars in millions)


Safety and

Industrial


Transportation

and

Electronics


Health Care


Consumer


Corporate

and

Unallocated


Elimination

of Dual

Credit


Total

Company

Net sales


$

3,235



$

2,450



$

2,249



$

1,525



$

3



$

(520)



$

8,942

















Business segment operating income (measure of segment operating performance)


620



465



529



332



(27)



(131)



1,788


Add/(subtract):















Depreciation and amortization


149



106



158



37



26





476


Adjustments for special items:















None















Adjusted EBITDA (non-GAAP measure) (d)


$

769



$

571



$

687



$

369



$

(1)



$

(131)



$

2,264

















Adjusted EBITDA margin (non-GAAP measure) (d)


23.8

%


23.3

%


30.5

%


24.2

%






25.3

%

































Adjusted EBITDA (non-GAAP measure)
Three months ended September 30, 2020 (dollars in millions)


Safety and

Industrial


Transportation

and

Electronics


Health Care


Consumer


Corporate

and

Unallocated


Elimination

of Dual

Credit


Total

Company

Net sales


$

3,017



$

2,316



$

2,160



$

1,412



$

(2)



$

(553)



$

8,350

















Business segment operating income (measure of segment operating performance)


774



514



493



343



(73)



(142)



1,909


Add/(subtract):















Depreciation and amortization


149



99



160



35



38





481


Adjustments for special items:















None















Adjusted EBITDA (non-GAAP measure) (d)


$

923



$

613



$

653



$

378



$

(35)



$

(142)



$

2,390

















Adjusted EBITDA margin (non-GAAP measure) (d)


30.6

%


26.5

%


30.2

%


26.8

%






28.6

%




Adjusted EBITDA (non-GAAP measure)

Nine months ended September 30, 2021 (dollars in millions)


Safety and

Industrial


Transportation

and

Electronics


Health Care


Consumer


Corporate

and

Unallocated


Elimination

of Dual

Credit


Total

Company

Net sales


$

9,816



$

7,463



$

6,775



$

4,380



$

2



$

(1,693)



$

26,743

















Business segment operating income (measure of segment operating performance)


2,149



1,602



1,614



932



(116)



(428)



5,753


Add/(subtract):















Depreciation and amortization


440



308



477



108



75





1,408


Adjustments for special items:















None















Adjusted EBITDA (non-GAAP measure) (d)


$

2,589



$

1,910



$

2,091



$

1,040



$

(41)



$

(428)



$

7,161

















Adjusted EBITDA margin (non-GAAP measure) (d)


26.4

%


25.6

%


30.9

%


23.7

%






26.8

%




Adjusted EBITDA (non-GAAP measure)

Nine months ended September 30, 2020 (dollars in millions)


Safety and

Industrial


Transportation

and

Electronics


Health Care


Consumer


Corporate

and

Unallocated


Elimination

of Dual

Credit


Total

Company

Net sales


$

8,601



$

6,492



$

6,087



$

3,893



$

(1)



$

(1,471)



$

23,601

















Business segment operating income (measure of segment operating performance)


2,091



1,338



1,246



886



125



(374)



5,312


Add/(subtract):















Depreciation and amortization


417



316



468



104



108





1,413


Adjustments for special items:















Significant litigation-related charges/benefits










17





17


(Gain)/loss on sale of businesses










(389)





(389)


Divestiture-related restructuring actions










55





55


Adjusted EBITDA (non-GAAP measure) (d)


$

2,508



$

1,654



$

1,714



$

990



$

(84)



$

(374)



$

6,408

















Adjusted EBITDA margin (non-GAAP measure) (d)


29.2

%


25.5

%


28.2

%


25.4

%






27.2

%


______________________________________

(d)

Adjusted EBITDA and adjusted EBITDA margin are not defined under U.S. GAAP. Therefore, adjusted EBITDA and adjusted EBITDA margin should not be considered a substitute for other measures prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by other companies. The Company defines adjusted EBITDA as net income attributable to 3M, adjusted for net income/(loss) attributable to noncontrolling interest, (income)/loss from unconsolidated subsidiaries, provision for income taxes, other expense/(income), depreciation and amortization expense, and special items. For business segments, the Company defines adjusted EBITDA as business segment operating income (3M's measure of segment operating performance) adjusted for depreciation and amortization expense. The Company defines adjusted EBITDA margin as adjusted EBITDA divided by net sales. Special items for the periods presented include the items described in the section entitled "Description of Special Items". The Company considers these non-GAAP measures in evaluating and managing the Company's operations. The Company believes adjusted EBITDA and adjusted EBITDA margin are meaningful to investors as they provide useful analyses of ongoing underlying operating trends.

 

Net Debt (non-GAAP measure)


September 30,
2021


December 31,
2020

Total debt


$

18,165



$

18,795


Less: Cash, cash equivalents and marketable securities


5,763



5,068


Net debt (e)


$

12,402



$

13,727



______________________________________

(e)

Net debt is not defined under U.S. GAAP and may not be computed the same as similarly titled measures used by other companies. The Company defines net debt as total debt less the total of cash, cash equivalents and current and long-term marketable securities. 3M believes net debt is meaningful to investors as 3M considers net debt and its components to be an important indicator of liquidity and a guiding measure of capital structure strategy.

 

3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)

Description of Special Items:

In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP measures that incorporate adjustments for the impacts of special items. Special items incorporated in the preparation of these non-GAAP measures for the periods presented include the items described below:

Significant litigation-related charges/benefits:

  • In the first quarter of 2020, 3M recorded a net pre-tax charge of $17 million ($13 million after tax) related to PFAS (certain perfluorinated compounds) matters. The charge was more than offset by a reduction in tax expense of $52 million related to resolution of tax treatment with authorities regarding the previously disclosed 2018 agreement reached with the State of Minnesota that resolved the Natural Resources Damages lawsuit. These items, in aggregate, resulted in a $39 million after-tax benefit. In the third quarter of 2021 and 2020, 3M made payments of approximately $7 million and $13 million, respectively, related to significant litigation-related matters. In the first nine months of 2021 and 2020, 3M made payments of approximately $14 million and $94 million, respectively, related to significant litigation-related matters.

Gain/loss on sale of businesses:

  • In the first quarter of 2020, 3M recorded a pre-tax gain of $2 million ($1 million loss after tax) related to the sale of its advanced ballistic-protection business and recognition of certain contingent consideration. In the second quarter of 2020, 3M recorded a pre-tax gain of $387 million ($304 million after tax) related to the sale of its drug delivery business.

Divestiture-related restructuring actions:

  • In the third quarter and first nine months of 2021, 3M made payments of approximately $2 million and $7 million, respectively, associated with divestiture-related restructuring actions.
  • In the second quarter of 2020, following the divestiture of substantially all of the drug delivery business, management approved and committed to undertake certain restructuring actions addressing corporate functional costs and manufacturing footprint across 3M in relation to the magnitude of amounts previously allocated/burdened to the divested business. As a result, 3M recorded a pre-tax charge of $55 million ($46 million after tax).

Enactment/measurement period adjustments related to the Tax Cuts and Jobs Act (TCJA)

  • In the first nine months of 2021, 3M made payments of approximately $77 million related to the transition tax expense incurred as a result of the 2017 enactment of the TCJA. In the third quarter of 2020, 3M made payments of approximately $33 million related to the transition tax expense incurred as a result of the 2017 enactment of the TCJA.

 


3M Company and Subsidiaries

SALES CHANGE ANALYSIS (f)

(Unaudited)




Three months ended September 30, 2021

Sales Change Analysis By Geographic Area


Americas


Asia-

Pacific


Europe,

Middle

East and

Africa


World-

Wide

Volume – organic


5.4

%


5.1

%


3.1

%


4.9

%

Price


2.0



0.5



1.1



1.4


Organic local-currency sales


7.4



5.6



4.2



6.3


Divestitures









Translation


0.5



1.2



1.0



0.8


Total sales change


7.9

%


6.8

%


5.2

%


7.1

%




Three months ended September 30, 2021

Worldwide Sales Change By Business Segment


Organic local-

currency sales


Acquisitions


Divestitures


Translation


Total sales

change

Safety and Industrial


6.1

%


%


%


1.1

%


7.2

%

Transportation and Electronics


5.1







0.7



5.8


Health Care


3.3







0.8



4.1


Consumer


7.6







0.5



8.1


Total Company


6.3







0.8



7.1





Nine months ended September 30, 2021

Sales Change Analysis By Geographic Area


Americas


Asia-

Pacific


Europe,

Middle

East and

Africa


World-

Wide

Volume – organic


11.2

%


11.1

%


8.6

%


10.7

%

Price


1.3



(0.1)



0.8



0.8


Organic local-currency sales


12.5



11.0



9.4



11.5


Divestitures


(0.8)





(1.5)



(0.7)


Translation


0.5



3.7



6.2



2.5


Total sales change


12.2

%


14.7

%


14.1

%


13.3

%




Nine months ended September 30, 2021

Worldwide Sales Change By Business Segment


Organic local-

currency sales


Acquisitions


Divestitures


Translation


Total sales

change

Safety and Industrial


11.0

%


%


%


3.1

%


14.1

%

Transportation and Electronics


12.4







2.6



15.0


Health Care


11.4





(2.7)



2.6



11.3


Consumer


10.8







1.7



12.5


Total Company


11.5





(0.7)



2.5



13.3



______________________________________

(f)  

Total sales change is calculated based on reported sales results. The components of sales change include organic local-currency sales, acquisitions, divestitures, and translation. Organic local-currency sales include both organic volume impacts (which excludes acquisition and divestiture impacts) and selling price changes. Acquisition and divestiture impacts are measured separately for the first 12 months post-transaction.


 

3M Company and Subsidiaries
BUSINESS SEGMENTS
(Unaudited)

3M discloses business segment operating income as its measure of segment profit/loss, reconciled to both total 3M operating income and income before taxes. Note 19 to 3M's consolidated financial statements in its 2020 Annual Report on Form 10-K describes 3M's business segments and measure of segment operating performance used by 3M's chief operating decision maker (CODM). As discussed therein, the measure of segment operating performance includes dual credit for certain related operating income and excludes certain expenses and income that are not allocated to business segments and instead reflected in Corporate and Unallocated. Additionally, the following special items are excluded from business segment operating income and, instead, are included within Corporate and Unallocated: significant litigation-related charges/benefits, gain/loss on sale of businesses, and divestiture-related restructuring actions.

Effective in the first quarter of 2021, the measure of segment operating performance used by 3M's CODM changed and, as a result, 3M's disclosed measure of segment profit/loss (business segment operating income) was updated. The change to business segment operating income aligns with the update to how the CODM assesses performance and allocates resources for the Company's business segments. The change included the following:

Changes in cost attribution

The extent of allocation and method of attribution of certain net costs were updated to result in fewer items remaining in Corporate and Unallocated and, instead, including them in 3M's business segments' operating performance. Previously, a larger portion of ongoing corporate staff costs and costs associated with centrally managed material resource centers was retained in Corporate and Unallocated. In addition, portions of pension costs and costs associated with certain centrally managed but ongoing business-related legal matters, along with certain insurance-related costs, were retained in Corporate and Unallocated.

Continued alignment of customer account activity

As part of 3M's regular customer-focus initiatives, the Company realigned certain customer account activity ("sales district") to correlate with the primary divisional product offerings in various countries and reduce complexity for customers when interacting with multiple 3M businesses. This impacted the amount of dual credit certain business segments receive as a result of sales district attribution.

Also effective in the first quarter of 2021, within 3M's Consumer business segment, certain safety products formerly within the Construction and Home Improvement Division and the Stationery and Office Division were moved to the newly-named Consumer Health and Safety Division (formerly the Consumer Health Care Division).

The financial information presented herein reflects the impact of the preceding changes for all periods presented.

BUSINESS SEGMENT INFORMATION


Three months ended September 30,


Nine months ended September 30,

NET SALES



(Millions)


2021


2020


2021


2020

Safety and Industrial


$

3,235



$

3,017



$

9,816



$

8,601


Transportation and Electronics


2,450



2,316



7,463



6,492


Health Care


2,249



2,160



6,775



6,087


Consumer


1,525



1,412



4,380



3,893


Corporate and Unallocated


3



(2)



2



(1)


Elimination of Dual Credit


(520)



(553)



(1,693)



(1,471)


Total Company


$

8,942



$

8,350



$

26,743



$

23,601



BUSINESS SEGMENT INFORMATION


Three months ended September 30,


Nine months ended September 30,

OPERATING INCOME



(Millions)


2021


2020


2021


2020

Safety and Industrial


$

620



$

774



$

2,149



$

2,091


Transportation and Electronics


465



514



1,602



1,338


Health Care


529



493



1,614



1,246


Consumer


332



343



932



886


Elimination of Dual Credit


(131)



(142)



(428)



(374)


Total business segment operating income


1,815



1,982



5,869



5,187


Corporate and Unallocated









Special items:









Significant litigation-related (charges)/benefits








(17)


Gain/(loss) on sale of businesses








389


Divestiture-related restructuring actions








(55)


Other corporate expense - net


(27)



(73)



(116)



(192)


Total Corporate and Unallocated


(27)



(73)



(116)



125


Total Company operating income


1,788



1,909



5,753



5,312











Other expense/(income), net


31



83



113



248


Income before income taxes


$

1,757



$

1,826



$

5,640



$

5,064


 

About 3M

At 3M, we apply science in collaborative ways to improve lives daily as our employees connect with customers all around the world. Learn more about 3M's creative solutions to the world's problems at www.3M.com or on Twitter @3M or @3MNews.

Contacts
3M
Investor Contacts:
Bruce Jermeland, 651-733-1807
or
Tony Riter, 651-733-1141
or
Diane Farrow, 612-202-2449
or
Media Contact:
Tim Post, 612-398-4190

Cision View original content:https://www.prnewswire.com/news-releases/3m-reports-third-quarter-2021-results-301408231.html

SOURCE 3M

FAQ

What were 3M's third-quarter sales for 2021?

3M's third-quarter sales for 2021 were $8.9 billion, a 7.1% increase year-on-year.

How did 3M's earnings per share perform in Q3 2021?

In Q3 2021, 3M's earnings per share remained flat at $2.45.

What is 3M's updated guidance for full-year 2021?

3M updated its full-year 2021 guidance to expect total sales growth of 9% to 10%.

How much cash flow did 3M generate in Q3 2021?

3M generated operating cash flow of $1.9 billion in Q3 2021.

What was the operating income for 3M in Q3 2021?

3M's operating income for Q3 2021 was $1.8 billion.

3M Company

NYSE:MMM

MMM Rankings

MMM Latest News

MMM Stock Data

70.65B
543.85M
0.12%
68.41%
1.29%
Conglomerates
Surgical & Medical Instruments & Apparatus
Link
United States of America
ST PAUL